Literature DB >> 16085910

Naturally acquired antibodies against four Enterococcus faecalis capsular polysaccharides in healthy human sera.

Markus Hufnagel1, Andrea Kropec, Christian Theilacker, Johannes Huebner.   

Abstract

Healthy human sera (HHS) contain naturally acquired enterococcal antibodies which promote neutrophil-mediated killing. The target antigens remain unknown. The present study used a capsular polysaccharide (CPS)-enzyme-linked immunosorbent assay (ELISA) to investigate whether the HHS antibodies of 12 healthy donors bound to the CPS of four E. faecalis serotypes (CPS-A to CPS-D) and then employed an opsonic-killing assay to determine if these antibodies mediated phagocyte-dependent killing. All HHS contained immunoglobulin G (IgG) and IgM antibodies directed against capsular polysaccharides of the four serotypes. Absorption of the sera with homologous and heterologous strains showed a majority of antibodies to be cross-reactive among the prototype strains. The susceptibility of the four prototype strains to opsonic killing varied. Opsonic killing of CPS-A and CPS-B strains was significantly higher than killing of CPS-C and CPS-D strains. Absorption studies revealed that the opsonic killing of HHS was only partially type specific, with cross-reactivity between CPS-A and CPS-B strains and between CPS-C and CPS-D strains. These data indicate that healthy individuals possess opsonic antibodies specific for CPS-A and CPS-B but only low titers of opsonic antibodies against CPS-C and CPS-D. Titers of opsonic antibodies did not correlate with antibody titers measured by ELISA. Whether this lack of correlation is due to the low frequency of opsonic antibodies or to increased resistance to the opsonophagocytic killing of some serotypes remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085910      PMCID: PMC1182185          DOI: 10.1128/CDLI.12.8.930-934.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  27 in total

Review 1.  Vancomycin-resistant enterococcal infections.

Authors:  B E Murray
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

2.  Opsonophagocytic assay as a potentially useful tool for assessing safety of enterococcal preparations.

Authors:  Markus Hufnagel; Steffi Koch; Andrea Kropec; Johannes Huebner
Journal:  Int J Food Microbiol       Date:  2003-12-01       Impact factor: 5.277

3.  Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis.

Authors:  Y Xu; K V Singh; X Qin; B E Murray; G M Weinstock
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Structure of an antigenic teichoic acid shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium.

Authors:  Y Wang; J Huebner; A O Tzianabos; G Martirosian; D L Kasper; G B Pier
Journal:  Carbohydr Res       Date:  1999-03-31       Impact factor: 2.104

5.  Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children.

Authors:  A Soininen; H Pursiainen; T Kilpi; H Käyhty
Journal:  J Infect Dis       Date:  2001-08-02       Impact factor: 5.226

6.  Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.

Authors:  J Huebner; A Quaas; W A Krueger; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

7.  Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistant Enterococcus faecium.

Authors:  R M Rakita; V C Quan; K Jacques-Palaz; K V Singh; R C Arduino; M Mee; B E Murray
Journal:  FEMS Immunol Med Microbiol       Date:  2000-08

8.  Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia.

Authors:  D M Musher; H M Phan; D A Watson; R E Baughn
Journal:  J Infect Dis       Date:  2000-06-30       Impact factor: 5.226

9.  Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis.

Authors:  R C Arduino; K Jacques-Palaz; B E Murray; R M Rakita
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 10.  Enterococcal infections: host response, therapeutic, and prophylactic possibilities.

Authors:  Stefanie Koch; Markus Hufnagel; Christian Theilacker; Johannes Huebner
Journal:  Vaccine       Date:  2004-02-17       Impact factor: 3.641

View more
  10 in total

1.  Detection of opsonic antibodies against Enterococcus faecalis cell wall carbohydrates in immune globulin preparations.

Authors:  M Hufnagel; K Sixel; F Hammer; A Kropec; I G Sava; C Theilacker; R Berner; J Huebner
Journal:  Infection       Date:  2014-05-23       Impact factor: 3.553

2.  Inhibition of the Classical Pathway of Complement Activation Impairs Bacterial Clearance during Enterococcus faecalis Infection.

Authors:  Youssif M Ali; Ramadan Hassan; Eman M Rabie Shehab El-Din; Abdelaziz Elgaml
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

3.  Capsular polysaccharide production in Enterococcus faecalis and contribution of CpsF to capsule serospecificity.

Authors:  Lance R Thurlow; Vinai Chittezham Thomas; Lynn E Hancock
Journal:  J Bacteriol       Date:  2009-08-14       Impact factor: 3.490

4.  The majority of a collection of U.S. endocarditis Enterococcus faecalis isolates obtained from 1974 to 2004 lack capsular genes and belong to diverse, non-hospital-associated lineages.

Authors:  Shahreen A Chowdhury; Sreedhar R Nallapareddy; Cesar A Arias; Barbara E Murray
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

5.  Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion.

Authors:  Lance R Thurlow; Vinai Chittezham Thomas; Sherry D Fleming; Lynn E Hancock
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

6.  Boosted rat natural xenoantibodies cross-react with Enterococcus faecalis by targeting melibiose and L-rhamnose.

Authors:  Magdiel Perez-Cruz; Cristina Costa; Rafael Mañez
Journal:  J Innate Immun       Date:  2013-11-15       Impact factor: 7.349

7.  Synthetic teichoic acid conjugate vaccine against nosocomial Gram-positive bacteria.

Authors:  Diana Laverde; Dominique Wobser; Felipe Romero-Saavedra; Wouter Hogendorf; Gijsbert van der Marel; Martin Berthold; Andrea Kropec; Jeroen Codee; Johannes Huebner
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

8.  Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease.

Authors:  Motoh Iwasa; Akiko Eguchi; Yasuyuki Tamai; Ryuta Shigefuku; Ryo Nakagawa; Hiroshi Hasegawa; Jumpei Kondo; Masayuki Morikawa; Eiji Miyoshi; Hayato Nakagawa
Journal:  Front Med (Lausanne)       Date:  2022-08-11

9.  Genetic diversity among Enterococcus faecalis.

Authors:  Shonna M McBride; Vincent A Fischetti; Donald J Leblanc; Robert C Moellering; Michael S Gilmore
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

10.  Exploration of the role of the virulence factor ElrA during Enterococcus faecalis cell infection.

Authors:  Natalia Nunez; Aurélie Derré-Bobillot; Stéphane Gaubert; Jean-Marie Herry; Julien Deschamps; Yu Wei; Thomas Baranek; Mustapha Si-Tahar; Romain Briandet; Pascale Serror; Cristel Archambaud
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.